| Angiotensin‐II type 1 receptor interaction is a major regulator for liver fibrosis development in rats H Yoshiji, S Kuriyama, J Yoshii, Y Ikenaka, R Noguchi, T Nakatani, ... Hepatology 34 (4), 745-750, 2001 | 584 | 2001 |
| Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay H Fukui, B Brauner, JC Bode, C Bode Journal of hepatology 12 (2), 162-169, 1991 | 546 | 1991 |
| Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis H Yoshiji, S Kuriyama, J Yoshii, Y Ikenaka, R Noguchi, DJ Hicklin, Y Wu, ... Gut 52 (9), 1347-1354, 2003 | 436 | 2003 |
| Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model H Yoshiji, S Kuriyama, Y Miyamoto, UP Thorgeirsson, DE Gomez, ... Hepatology 32 (6), 1248-1254, 2000 | 377 | 2000 |
| Evidence-based clinical practice guidelines for liver cirrhosis 2015 H Fukui, H Saito, Y Ueno, H Uto, K Obara, I Sakaida, A Shibuya, M Seike, ... Journal of gastroenterology 51, 629-650, 2016 | 366 | 2016 |
| Identification of insulin-producing cells derived from embryonic stem cells by zinc-chelating dithizone A Shiroi, M Yoshikawa, H Yokota, H Fukui, S Ishizaka, K Tatsumi, ... Stem cells 20 (4), 284-292, 2002 | 353 | 2002 |
| Localization of ADAMTS13 to the stellate cells of human liver M Uemura, K Tatsumi, M Matsumoto, M Fujimoto, T Matsuyama, ... Blood 106 (3), 922-924, 2005 | 349 | 2005 |
| Increased intestinal permeability and decreased barrier function: does it really influence the risk of inflammation? H Fukui Inflammatory intestinal diseases 1 (3), 135-145, 2016 | 341 | 2016 |
| Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse H Yoshiji, S Kuriyama, J Yoshii, Y Ikenaka, R Noguchi, T Nakatani, ... Hepatology 36 (4), 850-860, 2002 | 311 | 2002 |
| The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: possible role of the vascular endothelial growth factor H Yoshiji, S Kuriyama, M Kawata, J Yoshii, Y Ikenaka, R Noguchi, ... Clinical Cancer Research 7 (4), 1073-1078, 2001 | 293 | 2001 |
| Immunomodulatory effects of ursodeoxycholic acid on immune responses M Yoshikawa, T Tsujii, K Matsumura, J Yamao, Y Matsumura, R Kubo, ... Hepatology 16 (2), 358-364, 1992 | 276 | 1992 |
| The effect of inflammatory cytokines in alcoholic liver disease H Kawaratani, T Tsujimoto, A Douhara, H Takaya, K Moriya, T Namisaki, ... Mediators of inflammation 2013, 2013 | 265 | 2013 |
| Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance M Fujimoto, M Uemura, Y Nakatani, S Tsujita, K Hoppo, T Tamagawa, ... Alcoholism: Clinical and Experimental Research 24, 48S-54S, 2000 | 259 | 2000 |
| Protein kinase C lies on the signaling pathway for vascular endothelial growth factor-mediated tumor development and angiogenesis H Yoshiji, S Kuriyama, DK Ways, J Yoshii, Y Miyamoto, M Kawata, ... Cancer research 59 (17), 4413-4418, 1999 | 234 | 1999 |
| Imatinib mesylate (STI-571) attenuates liver fibrosis development in rats H Yoshiji, R Noguchi, S Kuriyama, Y Ikenaka, J Yoshii, K Yanase, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 288 (5 …, 2005 | 225 | 2005 |
| Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia H Fukui World journal of hepatology 7 (3), 425, 2015 | 218 | 2015 |
| Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma H Yoshiji, S Kuriyama, J Yoshii, Y Ikenaka, R Noguchi, DJ Hicklin, ... Hepatology 35 (4), 834-842, 2002 | 214 | 2002 |
| Leptin‐mediated neovascularization is a prerequisite for progression of nonalcoholic steatohepatitis in rats M Kitade, H Yoshiji, H Kojima, Y Ikenaka, R Noguchi, K Kaji, J Yoshii, ... Hepatology 44 (4), 983-991, 2006 | 203 | 2006 |
| Changes in the expression and localization of hepatocellular transporters and radixin in primary biliary cirrhosis H Kojima, AT Nies, J König, W Hagmann, H Spring, M Uemura, H Fukui, ... Journal of hepatology 39 (5), 693-702, 2003 | 189 | 2003 |
| The copper‐chelating agent, trientine, suppresses tumor development and angiogenesis in the murine hepatocellular carcinoma cells J Yoshii, H Yoshiji, S Kuriyama, Y Ikenaka, R Noguchi, H Okuda, ... International journal of cancer 94 (6), 768-773, 2001 | 187 | 2001 |
Akio WanakaNara Medical UniversityBestätigte E-Mail-Adresse bei naramed-u.ac.jp
